Advanced glycation end-products: a review
Top Cited Papers
- 5 February 2001
- journal article
- review article
- Published by Springer Nature in Diabetologia
- Vol. 44 (2) , 129-146
- https://doi.org/10.1007/s001250051591
Abstract
Advanced glycation end-products are a complex and heterogeneous group of compounds that have been implicated in diabetes related complications. At present it is not known if they are the cause or the consequence of the complications observed. We discuss the chemistry of advanced glycated end-product formation and their patho-biochemistry particularly in relation to the diabetic microvascular complications of retinopathy, neuropathy and nephropathy as well as their role in the accelerated vasculopathy observed in diabetes. The concept of carbonyl stress as a cause for advanced glycated end-product toxicity is mentioned. We discuss alterations in the concentrations of advanced glycated end-products in the body, particularly in relation to changes occuring with age, diabetes and its complications such as nephropathy. Problems relating to current methods of advanced glycated end-product detection and measurement are highlighted including the lack of a universally established method of detection or unit of measurement. Agents used for the treatment of advanced glycated end-product accumulation are reviewed, with an emphasis on the results of the recent phase III trials using aminoguanidine and diabetes related complications. [Diabetologia (2001) 44: 129–146]Keywords
This publication has 28 references indexed in Scilit:
- AGEs induce oxidative stress and activate protein kinase C-βIIin neonatal mesangial cellsAmerican Journal of Physiology-Renal Physiology, 2000
- Advanced glycation end products: A nephrologist's perspectiveAmerican Journal of Kidney Diseases, 2000
- Negative consequences of glycationMetabolism, 2000
- Experimental diabetic neuropathy: an updateDiabetologia, 1999
- Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications1999
- Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.Diabetes, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproductsNature Medicine, 1998
- Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis.Diabetes, 1998
- Glycemia and Regulation of Endothelial Adhesion MoleculesHormone and Metabolic Research, 1997